Insiders who reported open-market trades in the last 12 months at the companies Manohar K. Raheja files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Paul Badawi - $957K in SGHT purchases and sales in the last 12 months
Alison Bauerlein - $666K in SGHT purchases and sales in the last 12 months
Jeremy B. Hayden - $635K in SGHT purchases and sales in the last 12 months
David Badawi - $245K in SGHT purchases and sales in the last 12 months
James Rodberg - $203K in SGHT purchases and sales in the last 12 months
Staffan Encrantz - $185K in SGHT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Manohar K. Raheja is a corporate insider, tracked as EVP, Research Development of Sight Sciences, Inc. (SGHT). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Manohar K. Raheja last file a Form 4?
The most recent primary Form 4 on record is dated 31 August 2025, one of 6 filings going back to 2024.
Has Manohar K. Raheja been buying or selling stock?
Recorded transactions: 4 open-market purchases ($58K) and 0 open-market sales across all tracked filings.
Manohar K. Raheja is EVP, Research Development of Sight Sciences, Inc. (SGHT). 6 SEC Form 4 filings on record going back to 2024, most recently on 31 August 2025. Most recent open-market trade: bought $19K of SGHT on 9 December 2024. Lifetime open-market purchases: $58K.
Recent transactions
5
The latest 5 SEC Form 4 transactions reported by Manohar K. Raheja.
InsiderAlpha's records for Manohar K. Raheja go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $15K (4 buys totaling $58K). The largest single buy on record is $19K of SGHT in 2024. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.